The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Open accessAbstract
Cholangiocarcinoma (CCA) comprises a heterogeneous group of cancers with pathologic features of biliary tract differentiation, and is presumed to arise from the intra- or extrahepatic biliary tract. Two recent papers suggest these cancers may also arise directly from transdifferentiation of hepatocytes [1,2]. Gallbladder cancer is distinct from cholangiocarcinoma in epidemiology, pathobiology, clinical presentation and management, and should be considered a different form of biliary tract cancer [3].
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Self-citationEdge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
Self-citationInhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, J. A., Hickey, H., Beger, H., Fernandez-Cruz, L., Dervenis, C., Lacaine, F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032295 · Cited by 2,716
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
Tsao, M.-S., Sakurada, A., Cutz, J.-C., Zhu, C.-Q., Kamel-Reid, S., Squire, J., Lorimer, I., Zhang, T., Liu, N., Daneshmand, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050736 · Cited by 1,830
Going from evidence to recommendations
Guyatt, G. H., Oxman, A. D., Kunz, R., Falck-Ytter, Y., Vist, G. E., Liberati, A., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39493.646875.ae · Cited by 1,810
Pathology and Genetics of Tumours of the Digestive System
(2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01219.x · Cited by 1,314
Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution
DeOliveira, M. L., Cunningham, S. C., Cameron, J. L., Kamangar, F., Winter, J. M., Lillemoe, K. D., Choti, M. A., Yeo, C. J., & Schulick, R. D. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251366.62632.d3 · Cited by 1,300
Cholangiocarcinoma: A Spectrum of Intrahepatic, Perihilar, and Distal Tumors
Nakeeb, A., Pitt, H. A., Sohn, T. A., Coleman, J., Abrams, R. A., Piantadosi, S., Hruban, R. H., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00005 · Cited by 1,187
The Epidemiology of Cholangiocarcinoma
Shaib, Y., & El-Serag, H. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828889 · Cited by 1,132
Khan, S. A., Thomas, H. C., Davidson, B. R., & Taylor-Robinson, S. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67530-7 · Cited by 1,042
Self-citationIncreasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.25087 · Cited by 1,010
Self-citationRisk factors for cholangiocarcinoma
Tyson, G. L., & El-Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24351 · Cited by 956
Endo, I., Gonen, M., Yopp, A. C., Dalal, K. M., Zhou, Q., Klimstra, D., D'Angelica, M., DeMatteo, R. P., Fong, Y., Schwartz, L., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318176c4d3 · Cited by 865
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
Glimelius, B., Hoffman, K., Sjödén, P.-O., Jacobsson, G., Sellström, H., Enander, L.-K., Linné, T., & Svensson, C. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010676 · Cited by 797
Clinical diagnosis and staging of cholangiocarcinoma
Blechacz, B., Komuta, M., Roskams, T., & Gores, G. J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.131 · Cited by 747
Self-citationOkusaka, T., Nakachi, K., Fukutomi, A., Mizuno, N., Ohkawa, S., Funakoshi, A., Nagino, M., Kondo, S., Nagaoka, S., Funai, J., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605779 · Cited by 744
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Wu, Y.-M., Su, F., Kalyana-Sundaram, S., Khazanov, N., Ateeq, B., Cao, X., Lonigro, R. J., Vats, P., Wang, R., Lin, S.-F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0050 · Cited by 744
de Jong, M. C., Nathan, H., Sotiropoulos, G. C., Paul, A., Alexandrescu, S., Marques, H., Pulitano, C., Barroso, E., Clary, B. M., Aldrighetti, L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6519 · Cited by 729
Self-citationBorger, D. R., Tanabe, K. K., Fan, K. C., Lopez, H. U., Fantin, V. R., Straley, K. S., Schenkein, D. P., Hezel, A. F., Ancukiewicz, M., Liebman, H. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0386 · Cited by 728
Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
Chiang, D. Y., Villanueva, A., Hoshida, Y., Peix, J., Newell, P., Minguez, B., LeBlanc, A. C., Donovan, D. J., Thung, S. N., Solé, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0742 · Cited by 719
Self-citationJiao, Y., Pawlik, T. M., Anders, R. A., Selaru, F. M., Streppel, M. M., Lucas, D. J., Niknafs, N., Guthrie, V. B., Maitra, A., Argani, P., et al. (2013) · Nature Genetics · doi:10.1038/ng.2813 · Cited by 684
Self-citationRising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
Shaib, Y. H., Davila, J. A., McGlynn, K., & El-Serag, H. B. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.030 · Cited by 683
Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., McDonald, A. C., Carter, R., Tebbutt, N. C., Dervenis, C., Smith, D., et al. (2012) · JAMA · doi:10.1001/jama.2012.7352 · Cited by 597
Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., Botha, J. F., Mezrich, J. D., Chapman, W. C., Schwartz, J. J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.008 · Cited by 597
Self-citationSia, D., Hoshida, Y., Villanueva, A., Roayaie, S., Ferrer, J., Tabak, B., Peix, J., Sole, M., Tovar, V., Alsinet, C., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.001 · Cited by 575
Self-citationChanging international trends in mortality rates for liver, biliary and pancreatic tumours
Khan, S. A., Taylor-Robinson, S. D., Toledano, M. B., Beck, A., Elliott, P., & Thomas, H. C. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00297-0 · Cited by 570
Self-citationArai, Y., Totoki, Y., Hosoda, F., Shirota, T., Hama, N., Nakamura, H., Ojima, H., Furuta, K., Shimada, K., Okusaka, T., et al. (2014) · Hepatology · doi:10.1002/hep.26890 · Cited by 553
Andersen, J. B., Spee, B., Blechacz, B. R., Avital, I., Komuta, M., Barbour, A., Conner, E. A., Gillen, M. C., Roskams, T., Roberts, L. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.005 · Cited by 552
Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
Shaib, Y. H., El-Serag, H. B., Davila, J. A., Morgan, R., & McGlynn, K. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.048 · Cited by 546
Welzel, T. M., Graubard, B. I., Zeuzem, S., El-Serag, H. B., Davila, J. A., & McGlynn, K. A. (2011) · Hepatology · doi:10.1002/hep.24397 · Cited by 543
Cholangiocarcinomas can originate from hepatocytes in mice
Fan, B., Malato, Y., Calvisi, D. F., Naqvi, S., Razumilava, N., Ribback, S., Gores, G. J., Dombrowski, F., Evert, M., Chen, X., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63212 · Cited by 529
Self-citationPalmer, W. C., & Patel, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.022 · Cited by 517
Self-citationChan-on, W., Nairismägi, M.-L., Ong, C. K., Lim, W. K., Dima, S., Pairojkul, C., Lim, K. H., McPherson, J. R., Cutcutache, I., Heng, H. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2806 · Cited by 497
Worldwide trends in mortality from biliary tract malignancies
Patel, T. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-10 · Cited by 491
Self-citationExome sequencing of liver fluke–associated cholangiocarcinoma
Ong, C. K., Subimerb, C., Pairojkul, C., Wongkham, S., Cutcutache, I., Yu, W., McPherson, J. R., Allen, G. E., Ng, C. C. Y., Wong, B. H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2273 · Cited by 486
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials
Eckel, F., & Schmid, R. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603648 · Cited by 464
Gallbladder cancer: lessons from a rare tumour
Wistuba, I. I., & Gazdar, A. F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1429 · Cited by 454
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
Khan, S. A., Toledano, M. B., & Taylor-Robinson, S. D. (2008) · HPB · doi:10.1080/13651820801992641 · Cited by 431
Self-citationPatel, A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00744-3 · Cited by 425
Yoshikawa, D., Ojima, H., Iwasaki, M., Hiraoka, N., Kosuge, T., Kasai, S., Hirohashi, S., & Shibata, T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604129 · Cited by 404
Wang, P., Dong, Q., Zhang, C., Kuan, P.-F., Liu, Y., Jeck, W. R., Andersen, J. B., Jiang, W., Savich, G. L., Tan, T.-X., et al. (2013) · Oncogene · doi:10.1038/onc.2012.315 · Cited by 399
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998
Taylor-Robinson, S. D., Toledano, M. B., Arora, S., Keegan, T. J., Hargreaves, S., Beck, A., Khan, S. A., Elliott, P., & Thomas, H. C. (2001) · Gut · doi:10.1136/gut.48.6.816 · Cited by 381
Self-citationFluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma
Anderson, C. D., Rice, M. H., Pinson, C. W., Chapman, W. C., Chari, R. S., & Delbeke, D. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2003.10.003 · Cited by 377 · cited 3×
“In fact, FDG-PET was found to change the surgical management in up to 30% of patients [119,121,134].”
BackgroundMarsh, R., Talamonti, M. S., & Ji, Y. (2013) · Translational gastrointestinal cancer · Cited by 377
Pathology and genetics: Tumours of the digestive system
Haboubi, N. (2000) · Surgical Oncology · doi:10.1016/s0960-7404(01)00003-2 · Cited by 374
Welzel, T. M., McGlynn, K. A., Hsing, A. W., O'Brien, T. R., & Pfeiffer, R. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj234 · Cited by 372
Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
Sekiya, S., & Suzuki, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63065 · Cited by 348
Karakatsanis, A., Papaconstantinou, I., Gazouli, M., Lyberopoulou, A., Polymeneas, G., & Voros, D. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.21864 · Cited by 345
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
Tannapfel, A., Sommerer, F., Benicke, M., Katalinic, A., Uhlmann, D., Witzigmann, H., Hauss, J., & Wittekind, C. (2003) · Gut · doi:10.1136/gut.52.5.706 · Cited by 343
Pathological classification of intrahepatic cholangiocarcinoma based on a new concept
Nakanuma, Y. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i12.419 · Cited by 335
Sørensen, H. T., Friis, S., Olsen, J. H., Thulstrup, A. M., Mellemkjær, L., Linet, M., Trichopoulos, D., Vilstrup, H., & Olsen, J. (1998) · Hepatology · doi:10.1002/hep.510280404 · Cited by 328
Vilana, R., Forner, A., Bianchi, L., García-Criado, Á., Rimola, J., de Lope, C. R., Reig, M., Ayuso, C., Brú, C., & Bruix, J. (2010) · Hepatology · doi:10.1002/hep.23600 · Cited by 318
New staging system and a registry for perihilar cholangiocarcinoma
DeOliveira, M. L., Schulick, R. D., Nimura, Y., Rosen, C., Gores, G., Neuhaus, P., & Clavien, P.-A. (2011) · Hepatology · doi:10.1002/hep.24227 · Cited by 318
Self-citationA Proposed Staging System for Intrahepatic Cholangiocarcinoma
Nathan, H., Aloia, T. A., Vauthey, J.-N., Abdalla, E. K., Zhu, A. X., Schulick, R. D., Choti, M. A., & Pawlik, T. M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0180-z · Cited by 314
Self-citationEl‐Serag, H. B., Engels, E. A., Landgren, O., Chiao, E., Henderson, L., Amaratunge, H. C., & Giordano, T. P. (2009) · Hepatology · doi:10.1002/hep.22606 · Cited by 313
Trends in Organ Donation and Transplantation in the United States, 1999-2008
Wolfe, R. A., Roys, E. C., & Merion, R. M. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03021.x · Cited by 313
Classification, Diagnosis, and Management of Cholangiocarcinoma
Razumilava, N., & Gores, G. J. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.09.009 · Cited by 312
Self-citationEvaluation of Benign vs Malignant Hepatic Lesions With Positron Emission Tomography
Delbeke, D. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.5.510 · Cited by 312
Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma
Robles, R., Figueras, J., Turrión, V. S., Margarit, C., Moya, A., Varo, E., Calleja, J., Valdivieso, A., Valdecasas, J. C. G., López, P., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000108702.45715.81 · Cited by 304
Choi, S.-B., Kim, K.-S., Choi, J.-Y., Park, S.-W., Choi, J.-S., Lee, W.-J., & Chung, J.-B. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0631-1 · Cited by 304
Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
Bekaii-Saab, T., Phelps, M. A., Li, X., Saji, M., Goff, L., Kauh, J. S. W., O'Neil, B. H., Balsom, S., Balint, C., Liersemann, R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.9473 · Cited by 303
Rimola, J., Forner, A., Reig, M., Vilana, R., de Lope, C. R., Ayuso, C., & Bruix, J. (2009) · Hepatology · doi:10.1002/hep.23071 · Cited by 298
Corvera, C. U., Blumgart, L. H., Akhurst, T., DeMatteo, R. P., D’Angelica, M., Fong, Y., & Jarnagin, W. R. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.07.002 · Cited by 292
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
Khan, S. A., Emadossadaty, S., Ladep, N. G., Thomas, H. C., Elliott, P., Taylor-Robinson, S. D., & Toledano, M. B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.015 · Cited by 290
Self-citationRecurrence after operative management of intrahepatic cholangiocarcinoma
Hyder, O., Hatzaras, I., Sotiropoulos, G. C., Paul, A., Alexandrescu, S., Marques, H., Pulitano, C., Barroso, E., Clary, B. M., Aldrighetti, L., et al. (2013) · Surgery · doi:10.1016/j.surg.2012.12.005 · Cited by 281
Self-citationNuzzo, G. (2012) · Archives of Surgery · doi:10.1001/archsurg.2011.771 · Cited by 275
Valle, J. W., Wasan, H., Johnson, P., Jones, E., Dixon, L., Swindell, R., Baka, S., Maraveyas, A., Corrie, P., Falk, S., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605211 · Cited by 270
Self-citationCholangiocarcinoma: Modern advances in understanding a deadly old disease
Malhi, H., & Gores, G. J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.001 · Cited by 269
Self-citationOishi, N., Kumar, M. R., Roessler, S., Ji, J., Forgues, M., Budhu, A., Zhao, X., Andersen, J. B., Ye, Q.-H., Jia, H.-L., et al. (2012) · Hepatology · doi:10.1002/hep.25890 · Cited by 260
Shaib, Y. H., El-Serag, H. B., Nooka, A. K., Thomas, M., Brown, T. D., Patt, Y. Z., & Hassan, M. M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01104.x · Cited by 258
Donato, F., Gelatti, U., Tagger, A., Favret, M., Ribero, M. L., Callea, F., Martelli, C., Savio, A., Trevisi, P., & Nardi, G. (2001) · Cancer Causes & Control · doi:10.1023/a:1013747228572 · Cited by 247
SHIN, H.-R., LEE, C.-U., PARK, H.-J., SEOL, S.-Y., CHUNG, J.-M., CHOI, H.-C., AHN, Y.-O., & SHIGEMASTU, T. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.5.933 · Cited by 237
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
Sia, D., Tovar, V, Moeini, A., & Llovet, J. M. (2013) · Oncogene · doi:10.1038/onc.2012.617 · Cited by 235
Self-citationNakazawa, K., Dobashi, Y., Suzuki, S., Fujii, H., Takeda, Y., & Ooi, A. (2005) · The Journal of Pathology · doi:10.1002/path.1779 · Cited by 234
Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001
West, J., Wood, H., Logan, R. F. A., Quinn, M., & Aithal, G. P. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603127 · Cited by 234
Isomoto, H., Kobayashi, S., Werneburg, N. W., Bronk, S. F., Guicciardi, M. E., Frank, D. A., & Gores, G. J. (2005) · Hepatology · doi:10.1002/hep.20966 · Cited by 227
Self-citationThe American Joint Committee on Cancer: updating the strategies in cancer staging.
Greene, F. L. (2002) · PubMed · Cited by 226
Kobayashi, S., Werneburg, N. W., Bronk, S. F., Kaufmann, S. H., & Gores, G. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.010 · Cited by 226
Self-citationHoffmann, R.-T., Paprottka, P. M., Schön, A., Bamberg, F., Haug, A., Dürr, E.-M., Rauch, B., Trumm, C. T., Jakobs, T. F., Helmberger, T. K., et al. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-011-0142-x · Cited by 224
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma
Chen, L., Yan, H.-X., Yang, W., Hu, L., Yu, L.-X., Liu, Q., Li, L., Huang, D.-D., Ding, J., Shen, F., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.015 · Cited by 224
Shimoda, M., Farmer, D. G., Colquhoun, S. D., Rosove, M., Ghobrial, M. R., Yersiz, H., Chen, P., & Busuttil, R. W. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.29419 · Cited by 220
Sustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic Silencing
Isomoto, H., Mott, J. L., Kobayashi, S., Werneburg, N. W., Bronk, S. F., Haan, S., & Gores, G. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.037 · Cited by 219
Self-citationGoodman, Z. D. (2007) · Modern Pathology · doi:10.1038/modpathol.3800682 · Cited by 217
Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study
Lee, T. Y., Lee, S. S., Jung, S. W., Jeon, S. H., Yun, S.-C., Oh, H.-C., Kwon, S., Lee, S. K., Seo, D. W., Kim, M.-H., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01796.x · Cited by 217
Kim, J. Y., Kim, M.-H., Lee, T. Y., Hwang, C. Y., Kim, J. S., Yun, S.-C., Lee, S. S., Seo, D. W., & Lee, S. K. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01710.x · Cited by 216
Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study
Tan, J. C. C., Coburn, N. G., Baxter, N. N., Kiss, A., & Law, C. H. L. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9627-x · Cited by 213
Blechacz, B. R. A., & Gores, G. J. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.003 · Cited by 212
Self-citationGenetics of Biliary Tract Cancers and Emerging Targeted Therapies
Hezel, A. F., Deshpande, V., & Zhu, A. X. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4787 · Cited by 210
Park, J., Tadlock, L., Gores, G. J., & Patel, T. (1999) · Hepatology · doi:10.1002/hep.510300522 · Cited by 206
Self-citationHong, J. C. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.116 · Cited by 196
Welzel, T. M., Mellemkjaer, L., Gloria, G., Sakoda, L. C., Hsing, A. W., Ghormli, L. E., Olsen, J. H., & McGlynn, K. A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22283 · Cited by 195
Söreide, K., Körner, H., Havnen, J., & Söreide, J. A. (2004) · British Journal of Surgery · doi:10.1002/bjs.4815 · Cited by 193
Tannapfel, A., Benicke, M., Katalinic, A., Uhlmann, D., Köckerling, F., Hauss, J., & Wittekind, C. (2000) · Gut · doi:10.1136/gut.47.5.721 · Cited by 193
KrasG12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma
O'Dell, M. R., Li Huang, J., Whitney-Miller, C. L., Deshpande, V., Rothberg, P., Grose, V., Rossi, R. M., Zhu, A. X., Land, H., Bardeesy, N., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3596 · Cited by 192
McGlynn, K. A., Tarone, R. E., & El-Serag, H. B. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0811 · Cited by 190
Identification of a Cholangiocarcinoma-Like Gene Expression Trait in Hepatocellular Carcinoma
Woo, H. G., Lee, J.-H., Yoon, J.-H., Kim, C. Y., Lee, H.-S., Jang, J. J., Yi, N.-J., Suh, K.-S., Lee, K. U., Park, E. S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2823 · Cited by 190
Ibrahim, S. M., Mulcahy, M. F., Lewandowski, R. J., Sato, K. T., Ryu, R. K., Masterson, E. J., Newman, S. B., Benson, A., Omary, R. A., & Salem, R. (2008) · Cancer · doi:10.1002/cncr.23818 · Cited by 188
Endo, K., Yoon, B.-I., Pairojkul, C., Demetris, A. J., & Sirica, A. E. (2002) · Hepatology · doi:10.1053/jhep.2002.34435 · Cited by 188
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
Yamamoto, S., Kubo, S., Hai, S., Uenishi, T., Yamamoto, T., Shuto, T., Takemura, S., Tanaka, H., Yamazaki, O., Hirohashi, K., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02492.x · Cited by 187
Honjo, S., Srivatanakul, P., Sriplung, H., Kikukawa, H., Hanai, S., Uchida, K., Todoroki, T., Jedpiyawongse, A., Kittiwatanachot, P., Sripa, B., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21146 · Cited by 180
Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China
Zhou, Y.-M., Yin, Z.-F., Yang, J.-M., Li, B., Shao, W.-Y., Xu, F., Wang, Y.-L., & Li, D.-Q. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.632 · Cited by 171
Portal vein evaluation with US: comparison to angiography combined with CT arterial portography.
Bach, A. M., Hann, L. E., Brown, K. T., Getrajdman, G. I., Herman, S. K., Fong, Y., & Blumgart, L. H. (1996) · Radiology · doi:10.1148/radiology.201.1.8816536 · Cited by 169
Opisthorchis viverrini: The carcinogenic human liver fluke
Kaewpitoon, N. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.666 · Cited by 166
Kiefer, M. V., Albert, M., McNally, M., Robertson, M., Sun, W., Fraker, D., Olthoff, K., Christians, K., Pappas, S., Rilling, W., et al. (2011) · Cancer · doi:10.1002/cncr.25625 · Cited by 160
Park, S.-Y., Kim, J. H., Yoon, H.-J., Lee, I., Yoon, H., & Kim, K.-P. (2011) · Clinical Radiology · doi:10.1016/j.crad.2010.11.002 · Cited by 152
Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions
Voss, J. S., Holtegaard, L. M., Kerr, S. E., Fritcher, E. G. B., Roberts, L. R., Gores, G. J., Zhang, J., Highsmith, W. E., Halling, K. C., & Kipp, B. R. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.11.006 · Cited by 143
Self-citationKornek, G. V., Schuell, B., Laengle, F., Gruenberger, T., Penz, M., Karall, K., Depisch, D., Lang, F., & Scheithauer, W. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh096 · Cited by 143
Terada, T., Nakanuma, Y., & Sirica, A. E. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90229-5 · Cited by 133
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms
Melum, E., Karlsen, T. H., Schrumpf, E., Bergquist, A. M., Thorsby, E., Boberg, K. M., & Lie, B. A. (2007) · Hepatology · doi:10.1002/hep.21964 · Cited by 132
Lee, C. H., Chang, C. J., Lin, Y.-H., Yeh, C.-N., Chen, M. F., & Hsieh, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605063 · Cited by 131
Genome‐wide analysis of gene expression in human intrahepatic cholangiocarcinoma†
Obama, K., Ura, K., Li, M., Katagiri, T., Tsunoda, T., Nomura, A., Satoh, S., Nakamura, Y., & Furukawa, Y. (2005) · Hepatology · doi:10.1002/hep.20718 · Cited by 130
Jinawath, N., Chamgramol, Y., Furukawa, Y., Obama, K., Tsunoda, T., Sripa, B., Pairojkul, C., & Nakamura, Y. (2006) · Hepatology · doi:10.1002/hep.21330 · Cited by 130
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
Miyamoto, M., Ojima, H., Iwasaki, M., Shimizu, H., Kokubu, A., Hiraoka, N., Kosuge, T., Yoshikawa, D., Kono, T., Furukawa, H., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.199 · Cited by 129
Ducreux, M. P., Cutsem, E. V., Laethem, J. V., Gress, T. M., Jeziorski, K., Rougier, P. R., Wagener, T., Anak, Ö., Barón, B., & Nordlinger, B. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.026 · Cited by 126
Recurrence after surgical resection of intrahepatic cholangiocarcinoma
Yamamoto, M., Takasaki, K., Otsubo, T., Katsuragawa, H., & Katagiri, S. (2001) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340170039 · Cited by 123
Treatment of unresectable cholangiocarcinoma
Kuhlmann, J. B., Euringer, W., Spangenberg, H. C., Breidert, M., Blum, H. E., Harder, J., & Fischer, R. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283502241 · Cited by 122
Descriptive Epidemiology of Cholangiocarcinoma and Clonorchiasis in Korea
Shin, H., Oh, J., Lim, M. K., Shin, A., Kong, H., Jung, K., Won, Y., Park, S., Park, S., & Hong, S. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.7.1011 · Cited by 122
Anatomic and molecular pathology of intrahepatic cholangiocarcinoma
Nakanuma, Y., Harada, K., Ishikawa, A., Zen, Y., & Sasaki, M. (2003) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-002-0729-3 · Cited by 121
Cholangiocarcinoma: epidemiology and risk factors.
Bragazzi, M. C., Cardinale, V., Semeraro, R., et al. (2012) · IRIS Research product catalog (Sapienza University of Rome) · doi:10.3978/j.issn.2224-4778.2011.11.04 · Cited by 116
Shin, H.-R., Oh, J., Masuyer, E., Curado, M. P., Bouvard, V., Fang, Y., Wiangnon, S., Sripa, B., & Hong, S. (2010) · PubMed · Cited by 116
Polymorphism of glutathione S-transferase Omega gene and risk of cancer
Marahatta, S. B., Punyarit, P., Bhudisawasdi, V., Paupairoj, A., Wongkham, S., & Petmitr, S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.020 · Cited by 113
McLean, L. B., & Patel, T. C. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01350.x · Cited by 108
Self-citationGenetic profiling of intrahepatic cholangiocarcinoma
Andersen, J. B., & Thorgeirsson, S. S. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283523c7e · Cited by 104
Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany
von Hahn, T., Ciesek, S., Wegener, G., Plentz, R. R., Weismüller, T. J., Wedemeyer, H., Manns, M. P., Greten, T. F., & Malek, N. P. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.589472 · Cited by 100
Farazi, P. A., Zeisberg, M., Glickman, J. N., Zhang, Y., Kalluri, R., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4609 · Cited by 99
The antecedents of biliary cancer: a primary care case–control study in the United Kingdom
Grainge, M. J., West, J., Solaymani–Dodaran, M., Aithal, G. P., & Card, T. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604765 · Cited by 94
Incidence Rates of Intra- and Extrahepatic Cholangiocarcinomas in Denmark From 1978 Through 2002
Jepsen, P., Vilstrup, H., Tarone, R. E., Friis, S., & Sørensen, H. T. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk201 · Cited by 91
Descriptive epidemiology of cholangiocarcinoma in Italy
Alvaro, D., Crocetti, E., Ferretti, S., Bragazzi, M. C., & Capocaccia, R. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.10.009 · Cited by 90
Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma
Uenishi, T., Yamazaki, O., Tanaka, H., Takemura, S., Yamamoto, T., Tanaka, S., Nishiguchi, S., & Kubo, S. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9650-y · Cited by 86
Biliary Tract Cancers in Olmsted County, Minnesota, 1976–2008
Yang, J. D., Kim, B., Sanderson, S. O., Sauver, J. L. S., Yawn, B. P., Larson, J. J., Therneau, T. M., Roberts, L. R., Gores, G. J., & Kim, W. R. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.173 · Cited by 85
Self-citationSakoda, L. C., Gao, Y.-T., Chen, B. E., Chen, J., Rosenberg, P. S., Rashid, A., Deng, J., Shen, M.-C., Wang, B.-S., Han, T., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi314 · Cited by 70
Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma
Wong, N., Li, L., Tsang, K. S., Lai, P. B. S., To, K., & Johnson, P. J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00269-6 · Cited by 68
Tanaka, N., Yamakado, K., Nakatsuka, A., Fujii, A., Matsumura, K., & Takeda, K. (2002) · European Journal of Radiology · doi:10.1016/s0720-048x(01)00414-4 · Cited by 66
Li, R., Zhang, X., Ma, K., et al. (2012) · Abdominal Imaging · doi:10.1007/s00261-012-9854-x · Cited by 63
Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Koo, S. H., Ihm, C. H., Kwon, K. C., Park, J. W., Kim, J., & Kong, G. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00460-5 · Cited by 54
Self-citationLiu, Z., Zhou, Y., Shi, L., et al. (2011) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(11)60106-9 · Cited by 50
Huang, W., Gao, Y.-T., Rashid, A., Sakoda, L. C., Deng, J., Shen, M.-C., Wang, B., Han, T.-Q., Zhang, B.-H., Chen, B. E., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm247 · Cited by 48
Cholangiocarcinoma: Descriptive epidemiology and risk factors
de Martel, C., Plummer, M., & Franceschi, S. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2010.01.008 · Cited by 45
Positron emission tomography in hepatobiliary and pancreatic malignancies: a review
Lan, B. Y., Kwee, S. A., & Wong, L. L. (2012) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2011.07.025 · Cited by 39
Höblinger, A., Grünhage, F., Sauerbruch, T., & Lammert, F. (2009) · Digestion · doi:10.1159/000212990 · Cited by 37
Orthotopic liver transplantation in combination with neoadjuvant therapy
Rana, A. A., & Hong, J. C. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835168db · Cited by 34
Genetic Factors in the Pathogenesis of Cholangiocarcinoma
Wadsworth, C. A., Dixon, P. H., Wong, J. H.-M., Chapman, M. H., McKay, S. C., Sharif, A. W., Spalding, D. R. C., Pereira, S. P., Thomas, H. C., Taylor-Robinson, S. D., et al. (2011) · Digestive Diseases · doi:10.1159/000324688 · Cited by 32
Self-citationHeterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma
Mihalache, F., Höblinger, A., Grünhage, F., Krawczyk, M. J., Gärtner, B. C., Acalovschi, M., Sauerbruch, T., Lammert, F., & Zimmer, V. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04534.x · Cited by 30
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationEvidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
Cholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Self-citationHuman primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471
Banales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,376
Metadata
- Authors
- Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 60
- Issue
- 6
- Pages
- 1268-1289
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2011387799
- Cited by
- 1,511
- References
- 149
- FWCI
- 65.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.